Wild CP, Weiderpass E, Stewart BW, editors. World Cancer Report: Cancer research for cancer prevention. International Agency for Research on Cancer; 2020. NBK606505.
Clinton SK, Giovannucci EL, Hursting SD, The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet. Nutrition, physical Activity, and cancer: impact and future directions. J Nutr. 2020;150(4):663–71. https://doi.org/10.1093/jn/nxz268.
Henley SJ, Thomas CC, Sharapova SR, Momin B, Massetti GM, Winn DM, et al. Vital signs: disparities in Tobacco-Related cancer incidence and Mortality – United States, 2004–2013. MMWR Morb Mortal Wkly Rep. 2016;65(44):1212–8. https://doi.org/10.15585/mmwr.mm6544a3.
Hiza HA, Casavale KO, Guenther PM, Davis CA. Diet quality of Americans differs by age, sex, race/ethnicity, income, and education level. J Acad Nutr Diet. 2013;113(2):297–306. https://doi.org/10.1016/j.jand.2012.08.011.
Poirier AE, Ruan Y, Volesky KD, King WD, O’Sullivan DE, Gogna P, et al. The current and future burden of cancer attributable to modifiable risk factors in canada: summary of results. Prev Med. 2019;122:140–7. https://doi.org/10.1016/j.ypmed.2019.04.007.
Canadian Institutes of Health Research. How to integrate sex and gender into research. Government of Canada. 2019. Available from: https://cihr-irsc.gc.ca/e/50836.html
Johnson JL, Greaves L, Repta R. Better science with sex and gender: facilitating the use of a sex and gender-based analysis in health research. Int J Equity Health. 2009;8:14. https://doi.org/10.1186/1475-9276-8-14.
Lopes-Ramos CM, Quackenbush J, DeMeo DL. Genome-wide sex and gender differences in cancer. Front Oncol. 2020;10:597788. https://doi.org/10.3389/fonc.2020.597788.
Springer KW, Stellman JM, Jordan-Young RM. Beyond a catalogue of differences: a theoretical frame and good practice guidelines for researching sex/gender in human health. Soc Sci Med. 2012;74(11):1817–24. https://doi.org/10.1016/j.socscimed.2011.05.033.
Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174–82. https://doi.org/10.1158/1055-9965.EPI-08-1118.
Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187–96. https://doi.org/10.1007/s10654-011-9647-5.
Zheng D, Trynda J, Williams C, Vold JA, Nguyen JH, Harnois DM, et al. Sexual dimorphism in the incidence of human cancers. BMC Cancer. 2019;19(1):684. https://doi.org/10.1186/s12885-019-5902-z.
Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1389–97. https://doi.org/10.1158/1055-9965.EPI-20-0036.
Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F. Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017;18(12):1579–89. https://doi.org/10.1016/S1470-2045(17)30677-0.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Tosakoon S, Lawrence WR, Shiels MS, Jackson SS. Sex differences in cancer incidence rates by race and ethnicity: results from the surveillance, epidemiology, and end results (SEER) registry (2000–2019). Cancers. 2024;16(5):989. https://doi.org/10.3390/cancers16050989.
Selvaraj RC, Cioffi G, Waite KA, Jackson SS, Barnholtz-Sloan JS. A pre-cancer analysis of age and sex differences in cancer incidence and survival in the united States, 2001–2020. Cancers. 2025;17(3):378. https://doi.org/10.3390/cancers17030378.
Jackson SS, Marks MA, Katki HA, Cook MB, Hyun N, Freedman ND, et al. Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors. Cancer. 2022;128(19):3531–40. https://doi.org/10.1002/cncr.34390.
Khan M, Papier K, Pirie KL, Key TJ, Atkins J, Travis RC. Sex differences in cancer incidence: prospective analyses in the UK biobank. Br J Cancer. 2025;133(2):216–26. https://doi.org/10.1038/s41416-025-03028-y.
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40. https://doi.org/10.1097/XEB.0000000000000055.
Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022;378:e070849. https://doi.org/10.1136/bmj-2022-070849.
Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(Suppl 1):S92–107. https://doi.org/10.1038/bjc.2015.48.
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008.
Xue K, Li FF, Chen YW, Zhou YH, He J. Body mass index and the risk of cancer in women compared with men: a meta-analysis of prospective cohort studies. Eur J Cancer Prev. 2017;26(1):94–105. https://doi.org/10.1097/CEJ.0000000000000231.
Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007;96(9):1457–61. https://doi.org/10.1038/sj.bjc.6603703.
Liu H, Zhang Y, Ai M, Wang J, Jin B, Teng Z, et al. Body mass index can increase the risk of gallbladder cancer: a meta-analysis of 14 cohort studies. Med Sci Monit Basic Res. 2016;22:146–55. https://doi.org/10.12659/msmbr.901651.
Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48(14):2137–45. https://doi.org/10.1016/j.ejca.2012.02.063.
Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97(7):1005–8. https://doi.org/10.1038/sj.bjc.6603932.
Yao KF, Ma M, Ding GY, Li ZM, Chen HL, Han B, et al. Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI. Oncotarget. 2017;8(42):72959–71. https://doi.org/10.18632/oncotarget.20127.
Yang C, Lu Y, Xia H, Liu H, Pan D, Yang X, et al. Excess body weight and the risk of liver cancer: systematic review and a meta-analysis of cohort studies. Nutr Cancer. 2020;72(7):1085–97. https://doi.org/10.1080/01635581.2019.1664602.
Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007;13(31):4199–206. https://doi.org/10.3748/wjg.v13.i31.4199.
Fang X, Wei J, He X, Lian J, Han D, An P, et al. Quantitative association between body mass index and the risk of cancer: a global meta-analysis of prospective cohort studies. Int J Cancer. 2018;143(7):1595–603. https://doi.org/10.1002/ijc.31553.
Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125(1):171–80. https://doi.org/10.1002/ijc.24343.
Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE. 2013;8(1):e53916. https://doi.org/10.1371/journal.pone.0053916.
Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2533–47. https://doi.org/10.1158/1055-9965.EPI-07-0708.
Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev. 2010;11(1):19–30. https://doi.org/10.1111/j.1467-789X.2009.00613.x.
Wang J, Yang DL, Chen ZZ, Gou BF. Associations of body mass index with cancer incidence among populations, genders, and menopausal status: a systematic review and meta-analysis. Cancer Epidemiol. 2016;42:1–8. https://doi.org/10.1016/j.canep.2016.02.010.
Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis. 2009;11(6):547–63. https://doi.org/10.1111/j.1463-1318.2009.01766.x.
Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–65. https://doi.org/10.1093/ajcn/86.3.556.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. https://doi.org/10.1016/S0140-6736(08)60269-X.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. https://doi.org/10.1186/1471-2458-9-88.
Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, Ekbom A, et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer. 2013;49(3):642–57. https://doi.org/10.1016/j.ejca.2012.08.028.
Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012;36(7):868–75. https://doi.org/10.1016/j.leukres.2011.12.020.
Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer. 2008;122(6):1418–21. https://doi.org/10.1002/ijc.23176.
Abar L, Sobiecki JG, Cariolou M, Nanu N, Vieira AR, Stevens C, et al. Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies. Ann Oncol. 2019;30(4):528–41. https://doi.org/10.1093/annonc/mdz045.
Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc. 2013;27(12):4449–56. https://doi.org/10.1007/s00464-013-3127-9.
Chen Q, Wang J, Yang J, Jin Z, Shi W, Qin Y, et al. Association between adult weight gain and colorectal cancer: a dose-response meta-analysis of observational studies. Int J Cancer. 2015;136(12):2880–9. https://doi.org/10.1002/ijc.29331.
Schlesinger S, Lieb W, Koch M, Fedirko V, Dahm CC, Pischon T, et al. Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Obes Rev. 2015;16(7):607–19. https://doi.org/10.1111/obr.12286.
Youssef MR, Reisner ASC, Attia AS, Hussein MH, Omar M, LaRussa A, et al. Obesity and the prevention of thyroid cancer: impact of body mass index and weight change on developing thyroid cancer – pooled results of 24 million cohorts. Oral Oncol. 2021;112:105085. https://doi.org/10.1016/j.oraloncology.2020.105085.
Behrens G, Jochem C, Keimling M, Ricci C, Schmid D, Leitzmann MF. The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis. Eur J Epidemiol. 2014;29(3):151–70. https://doi.org/10.1007/s10654-014-9895-2.
Xie F, You Y, Huang J, Guan C, Chen Z, Fang M, et al. Association between physical activity and digestive-system cancer: an updated systematic review and meta-analysis. J Sport Health Sci. 2021;10(1):4–13. https://doi.org/10.1016/j.jshs.2020.09.009.
Buffart LM, Singh AS, van Loon EC, Vermeulen HI, Brug J, Chinapaw MJ. Physical activity and the risk of developing lung cancer among smokers: a meta-analysis. J Sci Med Sport. 2014;17(1):67–71. https://doi.org/10.1016/j.jsams.2013.02.015.
Jochem C, Leitzmann MF, Keimling M, Schmid D, Behrens G. Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(5):833–46. https://doi.org/10.1158/1055-9965.EPI-13-0699.
Chen GC, Lv DB, Pang Z, Liu QF. Fruits and vegetables consumption and risk of non-Hodgkin’s lymphoma: a meta-analysis of observational studies. Int J Cancer. 2013;133(1):190–200. https://doi.org/10.1002/ijc.27992.
Moazzen S, van der Sloot KWJ, Bock GH, Alizadeh BZ. Systematic review and meta-analysis of diet quality and colorectal cancer risk: is the evidence of sufficient quality to develop recommendations? Crit Rev Food Sci Nutr. 2021;61(16):2773–82. https://doi.org/10.1080/10408398.2020.1786353.
Schwingshackl L, Schwedhelm C, Hoffmann G, Knüppel S, Preterre AL, Iqbal K, et al. Food groups and risk of colorectal cancer. Int J Cancer. 2018;142(9):1748–58. https://doi.org/10.1002/ijc.31198.
Wu B, Yang D, Yang S, Zhang G. Dietary salt intake and gastric cancer risk: a systematic review and meta-analysis. Front Nutr. 2021;8:801228. https://doi.org/10.3389/fnut.2021.801228.
Galarraga V, Boffetta P. Coffee drinking and risk of lung cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25(6):951–7. https://doi.org/10.1158/1055-9965.EPI-15-0727.
Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis. 2006;27(7):1301–9. https://doi.org/10.1093/carcin/bgl024.
Bardia A, Tleyjeh IM, Cerhan JR, Sood AK, Limburg PJ, Erwin PJ et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc. 2008;83(1):23–34. https://doi.org/10.4065/83.1.23
Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P, et al. Beta-carotene supplementation and cancer risk: a systematic review and meta-analysis of randomized controlled trials. Int J Cancer. 2010;127(1):172–84. https://doi.org/10.1002/ijc.25008.
Boughanem H, Canudas S, Hernandez-Alonso P, Becerra-Tomás N, Babio N, Salas-Salvadó J, et al. Vitamin D intake and the risk of colorectal cancer: an updated meta-analysis and systematic review of case-control and prospective cohort studies. Cancers (Basel). 2021;13(11):2814. https://doi.org/10.3390/cancers13112814.
Turati F, Garavello W, Tramacere I, Pelucchi C, Galeone C, Bagnardi V, et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers: results from subgroup analyses. Alcohol Alcohol. 2013;48(1):107–18. https://doi.org/10.1093/alcalc/ags100.
Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999;94(10):1551–73. https://doi.org/10.1046/j.1360-0443.1999.9410155111.x.
Yu X, Chen J, Jiang W, Zhang D. Alcohol, alcoholic beverages and risk of esophageal cancer by histological type: a dose-response meta-analysis of observational studies. Alcohol Alcohol. 2020;55(5):457–67. https://doi.org/10.1093/alcalc/agaa047.
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580–93. https://doi.org/10.1038/bjc.2014.579.
Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011;22(9):1958–72. https://doi.org/10.1093/annonc/mdq653.
Lao Y, Li X, He L, Guan X, Li R, Wang Y, et al. Association between alcohol consumption and risk of bladder cancer: a dose-response meta-analysis of prospective cohort studies. Front Oncol. 2021;11:696676. https://doi.org/10.3389/fonc.2021.696676.
Galeone C, Malerba S, Rota M, Bagnardi V, Negri E, Scotti L, et al. A meta-analysis of alcohol consumption and the risk of brain tumours. Ann Oncol. 2013;24(2):514–23. https://doi.org/10.1093/annonc/mds432.
Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, Tanaka K, et al. Evaluation based on systematic review of epidemiological evidence among Japanese populations: tobacco smoking and total cancer risk. Jpn J Clin Oncol. 2005;35(7):404–11. https://doi.org/10.1093/jjco/hyi114.
Nishino Y, Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, et al. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2006;36(12):800–7. https://doi.org/10.1093/jjco/hyl112.
Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19(7):689–701. https://doi.org/10.1007/s10552-008-9136-z.
Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer. 2012;12:385. https://doi.org/10.1186/1471-2407-12-385.
Yu Y, Liu H, Zheng S, Ding Z, Chen Z, Jin W, et al. Gender susceptibility for cigarette smoking-attributable lung cancer: a systematic review and meta-analysis. Lung Cancer. 2014;85(3):351–60. https://doi.org/10.1016/j.lungcan.2014.07.004.
Lee PN, Forey BA, Thornton AJ, Coombs KJ. The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: A systematic review. F1000Res. 2018;7:204. https://doi.org/10.12688/f1000research.14002.1.
Wakai K, Inoue M, Mizoue T, Tanaka K, Tsuji I, Nagata C, et al. Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol. 2006;36(5):309–24. https://doi.org/10.1093/jjco/hyl025.
Liu X, Peveri G, Bosetti C, Bagnardi V, Specchia C, Gallus S, et al. Dose-response relationships between cigarette smoking and kidney cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019;142:86–93. https://doi.org/10.1016/j.critrevonc.2019.07.019.
Song F, Qureshi AA, Gao X, Li T, Han J. Smoking and risk of skin cancer: a prospective analysis and a meta-analysis. Int J Epidemiol. 2012;41(6):1694–705. https://doi.org/10.1093/ije/dys146.
Colamesta V, D’Aguanno S, Breccia M, Bruffa S, Cartoni C, La Torre G. Do the smoking intensity and duration, the years since quitting, the methodological quality and the year of publication of the studies affect the results of the meta-analysis on cigarette smoking and acute myeloid leukemia (AML) in adults? Crit Rev Oncol Hematol. 2016;99:376–88. https://doi.org/10.1016/j.critrevonc.2016.01.003.
Sinha DN, Abdulkader RS, Gupta PC. Smokeless tobacco-associated cancers: A systematic review and meta-analysis of Indian studies. Int J Cancer. 2016;138(6):1368–79. https://doi.org/10.1002/ijc.29884.
Weitkunat R, Sanders E, Lee PN. Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health. 2007;7:334. https://doi.org/10.1186/1471-2458-7-334.
Mu G, Wang J, Liu Z, Zhang H, Zhou S, Xiang Q, et al. Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):960. https://doi.org/10.1186/s12885-021-08691-x.
Lee PN, Hamling J. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med. 2009;7:36. https://doi.org/10.1186/1741-7015-7-36.
Botteri E, Borroni E, Sloan EK, Bagnardi V, Bosetti C, Peveri G, et al. Smoking and colorectal cancer Risk, overall and by molecular subtypes: A Meta-Analysis. Am J Gastroenterol. 2020;115(12):1940–9. https://doi.org/10.14309/ajg.0000000000000803.
Bauer GR. Sex and gender multidimensionality in epidemiologic research. Am J Epidemiol. 2023;192(1):122–32. https://doi.org/10.1093/aje/kwac173.
Day S, Mason R, Lagosky S, Rochon PA. Integrating and evaluating sex and gender in health research. Health Res Policy Syst. 2016;14(1):75. https://doi.org/10.1186/s12961-016-0147-7.
Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev. 2016;1:2. https://doi.org/10.1186/s41073-016-0007-6.
Krieger N. Genders, sexes, and health: what are the connections–and why does it matter? Int J Epidemiol. 2003;32(4):652–7. https://doi.org/10.1093/ije/dyg156.
Whelan E, Kalliala I, Semertzidou A, Raglan O, Bowden S, Kechagias K, et al. Risk factors for ovarian cancer: an umbrella review of the literature. Cancers (Basel). 2022;14(11). https://doi.org/10.3390/cancers14112708.
Yu H, Zhong X, Gao P, Shi J, Wu Z, Guo Z, et al. The potential effect of Metformin on cancer: an umbrella review. Front Endocrinol (Lausanne). 2019;10:617. https://doi.org/10.3389/fendo.2019.00617.
Zhao Y, Tang L, Shao J, Chen D, Jiang Y, Tang P, et al. The effectiveness of exercise on the symptoms in breast cancer patients undergoing adjuvant treatment: an umbrella review of systematic reviews and meta-analyses. Front Oncol. 2023;13:1222947. https://doi.org/10.3389/fonc.2023.1222947.
De Santis KK, Pieper D, Lorenz RC, Wegewitz U, Siemens W, Matthias K. User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary. BMC Med Res Methodol. 2023;23(1):63. https://doi.org/10.1186/s12874-023-01879-8.
Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34. https://doi.org/10.1016/j.jclinepi.2015.06.005.
Deeks J, Higgins J, Altman D, McKenzie J, Veroniki A. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. editors. Chapter 10: analysing data and undertaking meta-analyses [last updated November 2024]. Cochrane Handbook for Systematic Reviews of Interventions; 2024. Available from cochrane.org/handbook.
Feldman J, Brown GR, Deutsch MB, Hembree W, Meyer W, Meyer-Bahlburg HF, et al. Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):180–7. https://doi.org/10.1097/MED.0000000000000231.
Owen-Smith AA, Woodyatt C, Sineath RC, Hunkeler EM, Barnwell T, Graham A, et al. Perceptions of barriers to and facilitators of participation in health research among transgender people. Transgend Health. 2016;1(1):187–96. https://doi.org/10.1089/trgh.2016.0023.
Zhang Q, Goodman M, Adams N, Corneil T, Hashemi L, Kreukels B, et al. Epidemiological considerations in transgender health: A systematic review with focus on higher quality data. Int J Transgend Health. 2020;21(2):125–37. https://doi.org/10.1080/26895269.2020.1753136.
Ritz SA, Bauer G, Christiansen DM, Duchesne A, Trujillo AK, Maney DL, Operationalization. Measurement, and interpretation of Sex/Gender. In: DuBois LZ, Trujillo AK, McCarthy MM, editors. Sex and gender: toward transforming scientific practice. Springer; 2025. pp. 87–112.
Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1629–37. https://doi.org/10.1158/1055-9965.EPI-11-0246.
Kim HI, Lim H, Moon A. Sex differences in cancer: Epidemiology, genetics and therapy. Biomol Ther (Seoul). 2018;26(4):335–42. https://doi.org/10.4062/biomolther.2018.103.
White AM. Gender differences in the epidemiology of alcohol use and related harms in the united States. Alcohol Res. 2020;40(2):01. https://doi.org/10.35946/arcr.v40.2.01.
Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, et al. American cancer society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70(4):245–71. https://doi.org/10.3322/caac.21591.
Sasazuki S, Inoue M, Shimazu T, Wakai K, Naito M, Nagata C, et al. Evidence-based cancer prevention recommendations for Japanese. Jpn J Clin Oncol. 2018;48(6):576–86. https://doi.org/10.1093/jjco/hyy048.
Schüz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, et al. European code against cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015;39(Suppl 1):S1–10. https://doi.org/10.1016/j.canep.2015.05.009.